Older adults with diabetes experienced functional decline during the COVID-19 pandemic

Written by | 22 Apr 2024

Researchers found that approximately 1 in 5 older Canadian adults with diabetes and no pre-pandemic functional limitations developed functional limitations for the first time during the COVID-19 pandemic. […]

This outdated diabetes drug still has something to offer

Written by | 17 Apr 2024

Thiazolidinediones (TZDs) are a class of drug that can be used to treat type 2 diabetes by reversing insulin resistance, one of the main hallmarks of the disease. […]

UH College of Pharmacy researcher examines trends in rising cost of medicine

Written by | 12 Apr 2024

Newly published research from the University of Houston College of Pharmacy reveals an alarming trend in diabetic medication expenditures. While pharmaceutical spending in the U.S. has long been […]

Reducing diabetes medication costs can help improve outcomes, especially for low-income patients

Written by | 17 Feb 2024

A new study led by researchers at the Harvard Pilgrim Health Care Institute has found that reducing out-of-pocket costs for patients with diabetes, especially those considered low income, […]

High weekly physical activity levels linked to lower kidney disease risk in diabetes + overweight/obesity

Written by | 9 Feb 2024

Clocking up high weekly levels of moderate to vigorous intensity physical activity is linked to a lower risk of developing chronic kidney disease in overweight/obese people with type […]

Diabetes drug appears to prevent substantial weight gain in female ex-smokers

Written by | 22 Dec 2023

Dulaglutide.  a Type 2 diabetes treatment, appears to significantly lower the risk of weight gain among women who have stopped smoking, researchers reported after a secondary analysis of […]

Science’s 2023 Breakthrough of the Year: GLP-1 agonists show promise for obesity-associated health problems

Written by | 21 Dec 2023

Science has named the development of glucagon like peptide-1 (GLP-1) agonists and this year’s discovery that these drugs can blunt obesity-associated health problems as its 2023 Breakthrough of The […]

Diabetes drugs appear to lower colorectal cancer risk

Written by | 16 Dec 2023

Glucagon-like receptor agonists (GLP-1 RAs), a class of type 2 diabetes drug treatments, appear to also reduce the risk of colorectal cancer (CRC) researchers reported on Dec. 7, […]

Under-the-skin implant could treat Type I diabetes

Written by | 12 Dec 2023

A collaboration between researchers from Cornell and University of Alberta, Edmonton, has created a new technique to treat Type 1 diabetes: implanting a device inside a pocket under […]

UK diabetes prevention program may have global impact

Written by | 20 Nov 2023

A nationwide programme to reduce the risk of developing diabetes in the UK is proven beyond reasonable doubt to work, a new study reveals. The positive effects observed […]

Weekly insulin injections have the potential to be as effective in diabetes management as now-common daily injection regimes

Written by | 2 Nov 2023

Insulin icodec, a once-weekly basal injection to treat type 1 diabetes, has the potential to be as effective in managing the condition as daily basal insulin treatments, according […]

Semaglutide (Ozempic/Wegovy) shows 3-year efficacy for blood sugar control and weight loss

Written by | 5 Oct 2023

Data from a “real world” study indicates that treatment with the semaglutide (Ozempic/Wegovy) for type 2 diabetes significantly improves both blood sugar control and weight loss for up […]

Newsletter Icon

Sign up to our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare news and e-journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Sign Up

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our email journals and publications.